Clinical Trial Detail

NCT ID NCT02268825
Title Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors University of Utah
Indications

gastroesophageal junction adenocarcinoma

biliary tract cancer

pancreatic carcinoma

colorectal cancer

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Pembrolizumab

Age Groups: adult

No variant requirements are available.